 cannot be routinely recommended.
A systematic review of 16 retrospective case series that
used a pharmacomechanical approach with a variety of
thrombolytic devices reported ⬎50% lysis in 83% to 100%
of patients. Although complication rates should be viewed
with caution, these studies reported no procedure-related
deaths or strokes, a ⬍1% incidence of PE, and no major
bleeding complications, although 